Both in Biotechnology
Black Hawk Acquisition vs Jasper Therapeutics
Over the past year BKHA returned −59.8% and JSPR returned −75.9%; their daily moves had a correlation of -0.02.
BKHA −59.8% JSPR −75.9%Growth of $1, one year, split-adjusted
| Metric | BKHA | JSPR |
|---|---|---|
| Price | $4.50 | $0.4692 |
| Market cap | $18.7M | $15.6M |
| Today | −19.21% | −8.20% |
| 1 month | −65.4% | −17.6% |
| 6 months | — | −48.3% |
| Year to date | −60.0% | −74.4% |
| 1 year | — | −74.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 164.3% | 75.9% |
| Short % of float | 2.6% | 22.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).